PERCEPTIVE ADVISORS LLC
Filing Date
Global Rank
#660
/ 8,586
▲ 3
Top Industry
Biotechnology
90.8%
3Y Alpha vs SPY
-8.9%
Period ended 3 months ago
Filed May 29, 2026 · 18d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+41.9%
SPY
+78.1%
Annualised alpha
-8.9%
Max drawdown
−46.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
90 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
12.9%
+1.8 pts
Top 5
35.4%
+5.6 pts
Top 10
51.6%
+7.8 pts
HHI
414
Diversified+95
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $5,091,752,531 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | +7,847,896 | 9,751,141 | $97,023,852 | |
| SABS | SAB Biotherapeutics, Inc. | +5,628,533 | 6,431,743 | $24,633,575 | |
| BCRX | Biocryst Pharmaceuticals Inc | +4,271,504 | 7,434,033 | $70,771,994 | |
| CNTA | Centessa Pharmaceuticals plc | +2,341,269 | 5,258,903 | $208,883,627 | |
| AVR | Anteris Technologies Global Corp. | +1,750,000 | 3,425,476 | $19,011,391 | |
| CRVS | Corvus Pharmaceuticals, Inc. | +1,600,000 | 2,292,441 | $33,538,411 | |
| DYN | Dyne Therapeutics, Inc. | +1,189,895 | 4,668,839 | $84,646,051 | |
| TENX | Tenax Therapeutics, Inc. | +1,008,640 | 1,447,782 | $23,150,034 | |
| SYRE | Spyre Therapeutics, Inc. | +714,000 | 3,783,225 | $190,825,869 | |
| ASND | Ascendis Pharma A/S | +450,000 | 1,531,421 | $350,281,925 | |
| XFOR | X4 Pharmaceuticals, Inc | +423,196 | 6,737,648 | $27,826,486 | |
| CTMX | CytomX Therapeutics, Inc. | +418,639 | 10,098,824 | $47,464,472 | |
| ROIV | Roivant Sciences Ltd. | +300,000 | 8,285,461 | $229,507,269 | |
| TNGX | Tango Therapeutics, Inc. | +295,118 | 808,153 | $16,906,560 | |
| ZYME | Zymeworks Inc. | +248,228 | 3,510,078 | $87,892,353 | |
| BBNX | Beta Bionics, Inc. | +240,000 | 842,944 | $8,446,298 | |
| ANRO | Alto Neuroscience, Inc. | +225,500 | 2,009,893 | $45,182,394 | |
| NRIX | Nurix Therapeutics, Inc. | +155,000 | 3,710,877 | $57,518,593 | |
| GH | Guardant Health, Inc. | +140,000 | 300,000 | $27,711,000 | |
| SLDB | Solid Biosciences Inc. | +73,107 | 11,906,646 | $85,727,851 | |
| PRAX | Praxis Precision Medicines, Inc. | +40,000 | 2,035,986 | $655,974,329 | |
| BLLN | BillionToOne, Inc. | +19,000 | 91,812 | $7,247,639 | |
| AXSM | Axsome Therapeutics, Inc. | +1,050 | 149,950 | $25,344,549 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PALI | Palisade Bio, Inc. | −3,121,851 | 8,928,149 | $15,624,260 | |
| IKT | Inhibikase Therapeutics, Inc. | −3,106,568 | 2,315,000 | $3,889,200 | |
| IRD | Opus Genetics, Inc. | −2,489,158 | 1,835,842 | $8,353,081 | |
| VRDN | Viridian Therapeutics, Inc.DE | −1,871,874 | 1,170,829 | $22,901,415 | |
| OMDA | Omada Health, Inc. | −1,610,000 | 786,330 | $9,884,168 | |
| IVVD | Invivyd, Inc. | −925,863 | 20,859,303 | $27,117,093 | |
| APGE | Apogee Therapeutics, Inc. | −790,267 | 1,540,384 | $129,654,121 | |
| SION | Sionna Therapeutics, Inc. | −520,659 | 658,439 | $26,396,819 | |
| ADMA | Adma Biologics, Inc. | −416,235 | 467,233 | $4,209,769 | |
| IMVT | Immunovant, Inc. | −397,507 | 1,597,383 | $39,678,993 | |
| NBIX | Neurocrine Biosciences Inc | −266,000 | 65,050 | $8,569,687 | |
| BLTE | Belite Bio, Inc | −262,260 | 151,979 | $24,231,531 | |
| CBIO | Crescent Biopharma, Inc. | −246,744 | 206,942 | $3,801,524 | |
| CTNM | Contineum Therapeutics, Inc. | −209,000 | 1,255,592 | $16,398,031 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −172,596 | 2,373,795 | $206,448,951 | |
| CPIX | Cumberland Pharmaceuticals Inc | −144,109 | 196,978 | $640,178 | |
| TVTX | Travere Therapeutics, Inc. | −135,629 | 4,142,551 | $123,075,190 | |
| ABVX | Abivax S.A. | −129,459 | 328,884 | $36,621,233 | |
| PTGX | Protagonist Therapeutics, Inc | −119,546 | 1,230,879 | $129,734,646 | |
| OBIO | Orchestra BioMed Holdings, Inc. | −89,350 | 5,037,906 | $21,411,100 | |
| AXGN | Axogen, Inc. | −86,828 | 697,312 | $23,101,946 | |
| AORT | Artivion, Inc. | −85,000 | 1,637,290 | $59,957,559 | |
| NUVL | Nuvalent, Inc. | −84,600 | 1,580,505 | $161,922,737 | |
| ORKA | Oruka Therapeutics, Inc. | −81,000 | 1,395,501 | $68,449,324 | |
| DRUG | Bright Minds Biosciences Inc. | −71,746 | 377,544 | $27,549,385 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
19 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1,000,000 | $50,800,000 | |
| IONS | Ionis Pharmaceuticals Inc | 504,000 | $37,845,360 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 1,755,799 | $37,644,330 | |
| DMRA | Damora Therapeutics, Inc. | 1,223,000 | $31,675,700 | |
| RVMD | Revolution Medicines, Inc. | 258,600 | $25,148,850 | |
| DBVT | DBV Technologies S.A. | 964,391 | $20,146,127 | |
| STRO | Sutro Biopharma, Inc. | 715,307 | $17,818,297 | |
| EVMN | Evommune, Inc. | 448,350 | $10,307,566 | |
| PHAT | Phathom Pharmaceuticals, Inc. | 925,000 | $10,276,750 | |
| TWST | Twist Bioscience Corp | 150,000 | $7,128,000 | |
| SRZN | Surrozen, Inc./DE | 229,393 | $6,682,218 | |
| AGMB | Agomab Therapeutics NV | 600,000 | $6,294,000 | |
| EOLS | Evolus, Inc. | 1,286,862 | $5,289,002 | |
| OCUL | Ocular Therapeutix, Inc | 500,000 | $4,235,000 | |
| APLS | Apellis Pharmaceuticals, Inc. | 80,956 | $3,256,859 | |
| EDSA | Edesa Biotech, Inc. | 563,239 | $2,945,739 | |
| ADPT | Adaptive Biotechnologies Corp | 152,500 | $2,116,700 | |
| CORT | Corcept Therapeutics Inc | 50,000 | $2,015,500 | |
| XGN | Exagen Inc. | 114,893 | $344,679 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| EXAS | EXACT SCIENCES CORP | 1,200,487 | $121,921,459 | |
| ACLX | Arcellx, Inc. | 1,466,071 | $95,587,829 | |
| BSX | Boston Scientific Corp | 979,000 | $93,347,650 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 6,370,851 | $90,720,918 | |
| DHR | Danaher Corp /De/ | 200,000 | $45,784,000 | |
| IRON | Disc Medicine, Inc. | 450,743 | $35,793,501 | |
| PEN | Penumbra Inc | 110,529 | $34,364,571 | |
| CAI | Caris Life Sciences, Inc. | 1,136,206 | $30,654,837 | |
| PVLA | Palvella Therapeutics, Inc. | 266,287 | $27,872,260 | |
| KOD | Kodiak Sciences Inc. | 848,900 | $23,735,244 | |
| BIIB | Biogen Inc. | 124,000 | $21,822,760 | |
| ALDX | Aldeyra Therapeutics, Inc. | 4,185,632 | $21,681,573 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 259,545 | $20,501,459 | |
| GRAL | GRAIL, Inc. | 237,342 | $20,314,101 | |
| CVS | CVS HEALTH Corp | 220,000 | $17,459,200 | |
| GKOS | GLAUKOS Corp | 140,000 | $15,807,400 | |
| DXCM | Dexcom Inc | 225,758 | $14,983,558 | |
| SVRA | Savara Inc | 2,400,000 | $14,472,000 | |
| SEPN | Septerna, Inc. | 433,160 | $12,076,500 | |
| GOSS | Gossamer Bio, Inc. | 3,139,669 | $9,732,973 | |
| MPLT | MapLight Therapeutics, Inc. | 550,000 | $9,660,750 | |
| XENE | Xenon Pharmaceuticals Inc. | 200,791 | $8,999,452 | |
| KMTS | Kestra Medical Technologies, Ltd. | 285,000 | $7,558,200 | |
| CAPR | Capricor Therapeutics, Inc. | 242,100 | $6,987,006 | |
| BHVN | Biohaven Ltd. | 500,000 | $5,645,000 | |
| No positions match the current search. | ||||
90 positions ·
$5,091,752,531 total
· as of Mar 31, 2026
Showing 1–50
of 90 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ENSC |
Ensysce Biosciences, Inc.
Healthcare
|
Held | 86,666 | $46,712 | 0.00% | |
| XGN |
Exagen Inc.
Healthcare
|
NEW | 114,893 | $344,679 | 0.01% | |
| CPIX |
Cumberland Pharmaceuticals Inc
Healthcare
|
Reduced | 196,978 | $640,178 | 0.01% | |
| PTN |
Palatin Technologies Inc
Healthcare
|
Reduced | 61,945 | $1,079,081 | 0.02% | |
| MDLN |
Medline Inc.
Healthcare
|
Held | 28,000 | $1,246,000 | 0.02% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
NEW | 50,000 | $2,015,500 | 0.04% | |
| CNTB |
Connect Biopharma Holdings Ltd
Healthcare
|
Held | 792,696 | $2,076,863 | 0.04% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Held | 139,667 | $2,085,228 | 0.04% | |
| ADPT |
Adaptive Biotechnologies Corp
Healthcare
|
NEW | 152,500 | $2,116,700 | 0.04% | |
| EDSA |
Edesa Biotech, Inc.
Healthcare
|
NEW | 563,239 | $2,945,739 | 0.06% | |
| OM |
Outset Medical, Inc.
Healthcare
|
Held | 833,333 | $3,199,998 | 0.06% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
NEW | 80,956 | $3,256,859 | 0.06% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Reduced | 206,942 | $3,801,524 | 0.07% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Reduced | 2,315,000 | $3,889,200 | 0.08% | |
| ADMA |
Adma Biologics, Inc.
Healthcare
|
Reduced | 467,233 | $4,209,769 | 0.08% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
NEW | 500,000 | $4,235,000 | 0.08% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Held | 121,082 | $4,660,446 | 0.09% | |
| EOLS |
Evolus, Inc.
Healthcare
|
NEW | 1,286,862 | $5,289,002 | 0.10% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
NEW | 600,000 | $6,294,000 | 0.12% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
NEW | 229,393 | $6,682,218 | 0.13% | |
| TWST |
Twist Bioscience Corp
Healthcare
|
NEW | 150,000 | $7,128,000 | 0.14% | |
| BLLN |
BillionToOne, Inc.
Healthcare
|
Added | 91,812 | $7,247,639 | 0.14% | |
| IRD |
Opus Genetics, Inc.
Healthcare
|
Reduced | 1,835,842 | $8,353,081 | 0.16% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Added | 842,944 | $8,446,298 | 0.17% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 65,050 | $8,569,687 | 0.17% | |
| OMDA |
Omada Health, Inc.
Healthcare
|
Reduced | 786,330 | $9,884,168 | 0.19% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
NEW | 925,000 | $10,276,750 | 0.20% | |
| EVMN |
Evommune, Inc.
Healthcare
|
NEW | 448,350 | $10,307,566 | 0.20% | |
| ADGM |
Adagio Medical Holdings, Inc.
Healthcare
|
Held | 9,876,576 | $11,358,062 | 0.22% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Reduced | 105,026 | $12,395,168 | 0.24% | |
| OCS |
Oculis Holding AG
Healthcare
|
Held | 493,827 | $13,130,859 | 0.26% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Reduced | 8,928,149 | $15,624,260 | 0.31% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Reduced | 1,255,592 | $16,398,031 | 0.32% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 808,153 | $16,906,560 | 0.33% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
NEW | 715,307 | $17,818,297 | 0.35% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
Added | 3,425,476 | $19,011,391 | 0.37% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Held | 1,859,322 | $19,113,830 | 0.38% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
NEW | 964,391 | $20,146,127 | 0.40% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 673,923 | $21,087,050 | 0.41% | |
| OBIO |
Orchestra BioMed Holdings, Inc.
Healthcare
|
Reduced | 5,037,906 | $21,411,100 | 0.42% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Reduced | 1,170,829 | $22,901,415 | 0.45% | |
| AXGN |
Axogen, Inc.
Healthcare
|
Reduced | 697,312 | $23,101,946 | 0.45% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Added | 1,447,782 | $23,150,034 | 0.45% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Reduced | 151,979 | $24,231,531 | 0.48% | |
| SABS |
SAB Biotherapeutics, Inc.
Healthcare
|
Added | 6,431,743 | $24,633,575 | 0.48% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
NEW | 258,600 | $25,148,850 | 0.49% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 149,950 | $25,344,549 | 0.50% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Reduced | 658,439 | $26,396,819 | 0.52% | |
| IVVD |
Invivyd, Inc.
Healthcare
|
Reduced | 20,859,303 | $27,117,093 | 0.53% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Reduced | 377,544 | $27,549,385 | 0.54% |